Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinol-Binding Proteins, Plasma | 23 | 2020 | 93 | 5.700 |
Why?
|
Monosaccharide Transport Proteins | 66 | 2005 | 440 | 5.380 |
Why?
|
Insulin Resistance | 85 | 2023 | 3858 | 5.280 |
Why?
|
Adipocytes | 43 | 2023 | 1171 | 4.230 |
Why?
|
Glucose Transporter Type 4 | 59 | 2021 | 251 | 3.660 |
Why?
|
Glucose | 82 | 2021 | 4377 | 3.580 |
Why?
|
Adipose Tissue | 73 | 2022 | 3280 | 3.540 |
Why?
|
Insulin | 107 | 2023 | 6569 | 3.400 |
Why?
|
Muscle Proteins | 41 | 2005 | 1158 | 3.220 |
Why?
|
Esters | 10 | 2022 | 210 | 2.800 |
Why?
|
Fatty Acids | 21 | 2022 | 1804 | 2.670 |
Why?
|
Hypothalamus | 15 | 2016 | 1066 | 2.160 |
Why?
|
Stearic Acids | 6 | 2022 | 53 | 2.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 18 | 2015 | 91 | 2.000 |
Why?
|
Leptin | 26 | 2015 | 1589 | 1.930 |
Why?
|
Obesity | 57 | 2021 | 12643 | 1.840 |
Why?
|
Palmitic Acid | 5 | 2022 | 154 | 1.770 |
Why?
|
AMP-Activated Protein Kinases | 15 | 2018 | 607 | 1.660 |
Why?
|
Muscle, Skeletal | 46 | 2021 | 4920 | 1.610 |
Why?
|
Diabetes Mellitus, Type 2 | 38 | 2023 | 11699 | 1.510 |
Why?
|
Muscles | 31 | 2007 | 1608 | 1.460 |
Why?
|
Lipogenesis | 6 | 2017 | 210 | 1.330 |
Why?
|
Retinol-Binding Proteins | 6 | 2009 | 65 | 1.310 |
Why?
|
Protein Tyrosine Phosphatases | 11 | 2007 | 470 | 1.300 |
Why?
|
Multienzyme Complexes | 8 | 2006 | 687 | 1.240 |
Why?
|
Liver | 35 | 2021 | 7449 | 1.230 |
Why?
|
Blood Glucose | 39 | 2021 | 6237 | 1.140 |
Why?
|
Homeostasis | 25 | 2022 | 3348 | 1.100 |
Why?
|
Mice | 131 | 2022 | 81002 | 1.060 |
Why?
|
Glucose Intolerance | 12 | 2021 | 575 | 1.030 |
Why?
|
Energy Metabolism | 22 | 2021 | 2896 | 1.030 |
Why?
|
Hydroxy Acids | 2 | 2022 | 18 | 1.010 |
Why?
|
Animals | 190 | 2022 | 168368 | 1.010 |
Why?
|
Eating | 13 | 2018 | 1526 | 0.970 |
Why?
|
Amino Acids, Branched-Chain | 2 | 2021 | 249 | 0.960 |
Why?
|
Insulin-Secreting Cells | 2 | 2022 | 889 | 0.920 |
Why?
|
Adipose Tissue, White | 6 | 2020 | 345 | 0.920 |
Why?
|
Phosphatidylinositol 3-Kinases | 24 | 2012 | 2933 | 0.910 |
Why?
|
Isoenzymes | 9 | 2009 | 1720 | 0.900 |
Why?
|
Signal Transduction | 56 | 2021 | 23355 | 0.890 |
Why?
|
Diabetes Mellitus, Type 1 | 9 | 2022 | 3323 | 0.860 |
Why?
|
Receptor, Insulin | 20 | 2018 | 845 | 0.840 |
Why?
|
Diabetes Mellitus, Experimental | 15 | 2019 | 1125 | 0.830 |
Why?
|
Adenylate Kinase | 5 | 2013 | 100 | 0.830 |
Why?
|
Prealbumin | 4 | 2014 | 209 | 0.820 |
Why?
|
Subcutaneous Fat | 3 | 2018 | 392 | 0.810 |
Why?
|
Mice, Knockout | 45 | 2021 | 14558 | 0.790 |
Why?
|
Adaptive Immunity | 2 | 2016 | 709 | 0.780 |
Why?
|
Acyltransferases | 1 | 2022 | 290 | 0.750 |
Why?
|
Thiazolidinediones | 6 | 2020 | 474 | 0.750 |
Why?
|
Mice, Inbred C57BL | 36 | 2021 | 21863 | 0.730 |
Why?
|
Stearates | 1 | 2019 | 6 | 0.730 |
Why?
|
Body Weight | 25 | 2017 | 4660 | 0.710 |
Why?
|
Toll-Like Receptor 4 | 2 | 2020 | 560 | 0.680 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 4 | 2021 | 316 | 0.670 |
Why?
|
Glucose Tolerance Test | 18 | 2019 | 1149 | 0.660 |
Why?
|
Toll-Like Receptor 2 | 1 | 2020 | 354 | 0.650 |
Why?
|
Biological Transport | 25 | 2007 | 2118 | 0.650 |
Why?
|
Adipose Tissue, Brown | 8 | 2018 | 754 | 0.640 |
Why?
|
Dietary Fats | 12 | 2022 | 2013 | 0.630 |
Why?
|
Receptors, G-Protein-Coupled | 4 | 2019 | 1214 | 0.630 |
Why?
|
3T3 Cells | 13 | 2017 | 1103 | 0.610 |
Why?
|
Protein Kinase C | 7 | 2016 | 1223 | 0.580 |
Why?
|
Lipid Metabolism | 11 | 2022 | 1891 | 0.580 |
Why?
|
Adipogenesis | 3 | 2018 | 356 | 0.560 |
Why?
|
PPAR gamma | 5 | 2020 | 494 | 0.560 |
Why?
|
Paneth Cells | 1 | 2016 | 100 | 0.550 |
Why?
|
Inflammasomes | 1 | 2020 | 486 | 0.540 |
Why?
|
Immunoassay | 2 | 2012 | 750 | 0.540 |
Why?
|
Phosphorylation | 27 | 2020 | 8416 | 0.540 |
Why?
|
Gene Expression Regulation, Enzymologic | 5 | 2008 | 1213 | 0.530 |
Why?
|
Metabolomics | 2 | 2021 | 1460 | 0.520 |
Why?
|
Ventromedial Hypothalamic Nucleus | 2 | 2014 | 48 | 0.510 |
Why?
|
Nicotinamide N-Methyltransferase | 1 | 2014 | 10 | 0.500 |
Why?
|
Neurons | 13 | 2018 | 9336 | 0.490 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2012 | 104 | 0.480 |
Why?
|
Deoxyglucose | 8 | 2017 | 337 | 0.480 |
Why?
|
Th1 Cells | 2 | 2016 | 1055 | 0.480 |
Why?
|
Antigen-Presenting Cells | 2 | 2016 | 969 | 0.470 |
Why?
|
Gene Expression Regulation | 22 | 2021 | 12049 | 0.470 |
Why?
|
Glycogen | 11 | 2007 | 263 | 0.460 |
Why?
|
Immunity, Mucosal | 1 | 2016 | 491 | 0.440 |
Why?
|
Diet | 7 | 2021 | 7876 | 0.430 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2012 | 31 | 0.430 |
Why?
|
Oligonucleotides, Antisense | 1 | 2014 | 432 | 0.430 |
Why?
|
Glucose Transporter Type 1 | 10 | 2017 | 193 | 0.410 |
Why?
|
Thinness | 4 | 2014 | 475 | 0.410 |
Why?
|
Rats | 43 | 2021 | 24270 | 0.410 |
Why?
|
Fatty Liver | 3 | 2016 | 714 | 0.400 |
Why?
|
Hormones | 3 | 2007 | 880 | 0.400 |
Why?
|
Lipids | 6 | 2022 | 3307 | 0.400 |
Why?
|
Nuclear Proteins | 3 | 2017 | 5830 | 0.400 |
Why?
|
Male | 119 | 2021 | 349022 | 0.390 |
Why?
|
Mice, Transgenic | 27 | 2017 | 9734 | 0.390 |
Why?
|
Glycolysis | 6 | 2021 | 825 | 0.380 |
Why?
|
Hypoglycemia | 3 | 2016 | 855 | 0.380 |
Why?
|
Receptors, Adrenergic | 1 | 2011 | 155 | 0.380 |
Why?
|
Animal Feed | 3 | 2008 | 110 | 0.380 |
Why?
|
Proto-Oncogene Proteins | 10 | 2005 | 4555 | 0.370 |
Why?
|
Diabetes Mellitus | 14 | 2012 | 5702 | 0.370 |
Why?
|
Gene Expression | 16 | 2017 | 7788 | 0.370 |
Why?
|
Cyclin-Dependent Kinase 5 | 1 | 2010 | 112 | 0.370 |
Why?
|
Fasting | 12 | 2021 | 1587 | 0.370 |
Why?
|
Lipolysis | 4 | 2020 | 211 | 0.370 |
Why?
|
Fenretinide | 1 | 2009 | 12 | 0.360 |
Why?
|
Glucose Clamp Technique | 10 | 2016 | 266 | 0.360 |
Why?
|
Antigen Presentation | 1 | 2016 | 1286 | 0.360 |
Why?
|
Cell Survival | 2 | 2019 | 5877 | 0.360 |
Why?
|
Membrane Transport Proteins | 2 | 2010 | 1028 | 0.360 |
Why?
|
Serine | 3 | 2016 | 831 | 0.360 |
Why?
|
Macrophages | 7 | 2020 | 5631 | 0.350 |
Why?
|
Retinoids | 1 | 2009 | 96 | 0.340 |
Why?
|
Transcription Factors | 7 | 2017 | 12120 | 0.340 |
Why?
|
Models, Biological | 16 | 2020 | 9609 | 0.330 |
Why?
|
Glycogen Synthase | 5 | 2005 | 62 | 0.330 |
Why?
|
Insulin Receptor Substrate Proteins | 10 | 2010 | 563 | 0.330 |
Why?
|
Down-Regulation | 3 | 2014 | 2999 | 0.320 |
Why?
|
Hypoglycemic Agents | 5 | 2010 | 2861 | 0.320 |
Why?
|
Colitis | 1 | 2016 | 1146 | 0.320 |
Why?
|
RNA, Messenger | 30 | 2018 | 13002 | 0.320 |
Why?
|
Receptors, Androgen | 1 | 2014 | 1049 | 0.310 |
Why?
|
Proto-Oncogene Proteins c-akt | 13 | 2012 | 2507 | 0.310 |
Why?
|
Pro-Opiomelanocortin | 3 | 2015 | 163 | 0.310 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 4 | 1997 | 433 | 0.300 |
Why?
|
Enzyme Activation | 13 | 2009 | 3701 | 0.290 |
Why?
|
Mice, Obese | 7 | 2014 | 425 | 0.290 |
Why?
|
Transgenes | 3 | 2013 | 1010 | 0.290 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 6 | 2002 | 494 | 0.280 |
Why?
|
Triglycerides | 6 | 2022 | 2447 | 0.280 |
Why?
|
Mice, Inbred NOD | 2 | 2022 | 1867 | 0.280 |
Why?
|
Sirtuin 1 | 3 | 2014 | 243 | 0.280 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2016 | 4374 | 0.270 |
Why?
|
Humans | 113 | 2023 | 739398 | 0.270 |
Why?
|
Mitochondrial Proteins | 4 | 2011 | 989 | 0.260 |
Why?
|
Genes, ras | 3 | 1998 | 693 | 0.260 |
Why?
|
3T3-L1 Cells | 3 | 2020 | 197 | 0.260 |
Why?
|
Mass Spectrometry | 5 | 2018 | 2200 | 0.260 |
Why?
|
Vitamin A | 5 | 2014 | 613 | 0.260 |
Why?
|
Cardiomegaly | 3 | 2015 | 620 | 0.260 |
Why?
|
Blotting, Western | 13 | 2016 | 5181 | 0.260 |
Why?
|
Cells, Cultured | 18 | 2020 | 19220 | 0.250 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5522 | 0.250 |
Why?
|
Membrane Proteins | 5 | 2016 | 7862 | 0.250 |
Why?
|
Hunger | 1 | 2006 | 196 | 0.250 |
Why?
|
Carrier Proteins | 8 | 2021 | 5012 | 0.250 |
Why?
|
Cell Communication | 2 | 2012 | 1618 | 0.240 |
Why?
|
Immunity, Innate | 1 | 2016 | 2950 | 0.240 |
Why?
|
Aminopeptidases | 1 | 2004 | 91 | 0.240 |
Why?
|
Glucose Metabolism Disorders | 2 | 2018 | 54 | 0.230 |
Why?
|
Protein Kinases | 3 | 2006 | 1637 | 0.230 |
Why?
|
Rats, Sprague-Dawley | 12 | 2016 | 8299 | 0.230 |
Why?
|
Islets of Langerhans | 6 | 2019 | 1337 | 0.230 |
Why?
|
Stereoisomerism | 2 | 2021 | 628 | 0.220 |
Why?
|
Esterification | 1 | 2022 | 36 | 0.220 |
Why?
|
Phosphoproteins | 10 | 2008 | 2440 | 0.220 |
Why?
|
Insulin Antagonists | 1 | 2002 | 20 | 0.220 |
Why?
|
Feeding Behavior | 2 | 2006 | 3180 | 0.220 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 3 | 2014 | 452 | 0.210 |
Why?
|
Rats, Inbred Strains | 12 | 1991 | 2198 | 0.210 |
Why?
|
Female | 74 | 2021 | 378853 | 0.210 |
Why?
|
Intra-Abdominal Fat | 1 | 2007 | 590 | 0.210 |
Why?
|
src Homology Domains | 2 | 2000 | 365 | 0.210 |
Why?
|
Diglycerides | 1 | 2022 | 176 | 0.210 |
Why?
|
Glucagon | 4 | 2019 | 532 | 0.210 |
Why?
|
Chromans | 1 | 2002 | 122 | 0.210 |
Why?
|
Molecular Structure | 3 | 2021 | 1925 | 0.200 |
Why?
|
Promoter Regions, Genetic | 6 | 2013 | 5863 | 0.200 |
Why?
|
Ribosomal Protein S6 Kinases | 4 | 2010 | 205 | 0.200 |
Why?
|
Organ Specificity | 11 | 2013 | 2004 | 0.200 |
Why?
|
Tissue Distribution | 4 | 2014 | 2345 | 0.200 |
Why?
|
Potassium Channels | 2 | 2002 | 563 | 0.200 |
Why?
|
Growth Differentiation Factor 3 | 1 | 2020 | 11 | 0.190 |
Why?
|
Physical Conditioning, Animal | 3 | 2018 | 360 | 0.190 |
Why?
|
Inflammation | 7 | 2020 | 10534 | 0.190 |
Why?
|
Ion Channels | 4 | 2011 | 1056 | 0.190 |
Why?
|
Phosphoprotein Phosphatases | 4 | 2005 | 336 | 0.190 |
Why?
|
Arabidopsis Proteins | 1 | 2002 | 262 | 0.190 |
Why?
|
Molecular Sequence Data | 15 | 2016 | 18125 | 0.190 |
Why?
|
Tyrosine | 8 | 2005 | 1460 | 0.190 |
Why?
|
Metabolome | 2 | 2021 | 881 | 0.180 |
Why?
|
Oxidation-Reduction | 4 | 2021 | 2184 | 0.180 |
Why?
|
Coculture Techniques | 2 | 2016 | 1343 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 379 | 0.180 |
Why?
|
Adenoviridae | 7 | 2005 | 1095 | 0.180 |
Why?
|
Plant Proteins | 1 | 2002 | 361 | 0.180 |
Why?
|
Denervation | 1 | 2021 | 276 | 0.180 |
Why?
|
Fatty Acid-Binding Proteins | 3 | 2013 | 300 | 0.180 |
Why?
|
Multifactorial Inheritance | 1 | 2007 | 1174 | 0.180 |
Why?
|
Kinetics | 12 | 2009 | 6475 | 0.180 |
Why?
|
Oxygen | 4 | 2010 | 4158 | 0.170 |
Why?
|
Blood Pressure | 2 | 2015 | 8554 | 0.170 |
Why?
|
Joint Prosthesis | 2 | 2016 | 257 | 0.170 |
Why?
|
Dietary Sucrose | 1 | 2021 | 247 | 0.170 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4463 | 0.170 |
Why?
|
Glucosamine | 1 | 1999 | 131 | 0.170 |
Why?
|
Protein Isoforms | 4 | 2012 | 1725 | 0.160 |
Why?
|
Body Mass Index | 9 | 2021 | 12655 | 0.160 |
Why?
|
HLA Antigens | 1 | 2004 | 1382 | 0.160 |
Why?
|
Body Composition | 10 | 2017 | 2397 | 0.160 |
Why?
|
Intracellular Signaling Peptides and Proteins | 8 | 2017 | 2901 | 0.160 |
Why?
|
Palmitic Acids | 1 | 2017 | 54 | 0.160 |
Why?
|
Adiposity | 4 | 2018 | 1801 | 0.160 |
Why?
|
Integrases | 2 | 2013 | 532 | 0.160 |
Why?
|
Acetyl-CoA Carboxylase | 4 | 2007 | 78 | 0.150 |
Why?
|
Recombinant Proteins | 6 | 2014 | 6610 | 0.150 |
Why?
|
Phlorhizin | 3 | 2017 | 37 | 0.150 |
Why?
|
Myostatin | 1 | 2018 | 124 | 0.150 |
Why?
|
Cell Membrane | 11 | 2016 | 3747 | 0.150 |
Why?
|
Genes, Dominant | 3 | 2010 | 883 | 0.150 |
Why?
|
Overweight | 1 | 2008 | 2355 | 0.150 |
Why?
|
Quadriceps Muscle | 1 | 2018 | 142 | 0.150 |
Why?
|
Bone Marrow Cells | 2 | 2016 | 2515 | 0.150 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2020 | 4400 | 0.150 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 3 | 2015 | 51 | 0.150 |
Why?
|
Fatty Acids, Nonesterified | 3 | 2001 | 403 | 0.140 |
Why?
|
Carboxylesterase | 1 | 2016 | 31 | 0.140 |
Why?
|
Interferon Regulatory Factors | 1 | 2018 | 268 | 0.140 |
Why?
|
Biological Transport, Active | 4 | 2000 | 348 | 0.140 |
Why?
|
Proteins | 5 | 2002 | 6082 | 0.140 |
Why?
|
Sulfonylurea Compounds | 2 | 1995 | 200 | 0.140 |
Why?
|
Methylglucosides | 4 | 1990 | 36 | 0.140 |
Why?
|
Cyclic AMP | 2 | 2019 | 1470 | 0.140 |
Why?
|
Protein Phosphatase 1 | 4 | 2005 | 137 | 0.140 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2018 | 369 | 0.140 |
Why?
|
Dextran Sulfate | 1 | 2016 | 236 | 0.140 |
Why?
|
Brain | 8 | 2016 | 26345 | 0.130 |
Why?
|
Chromatography, Liquid | 2 | 2018 | 977 | 0.130 |
Why?
|
p21-Activated Kinases | 1 | 2016 | 128 | 0.130 |
Why?
|
Cytochalasin B | 6 | 2017 | 74 | 0.130 |
Why?
|
Gliclazide | 1 | 1995 | 4 | 0.130 |
Why?
|
Hydrolases | 1 | 2016 | 140 | 0.130 |
Why?
|
Hormones, Ectopic | 2 | 2005 | 40 | 0.130 |
Why?
|
Energy Intake | 5 | 2011 | 2135 | 0.130 |
Why?
|
ras Proteins | 3 | 1999 | 1062 | 0.130 |
Why?
|
Muscle Fibers, Skeletal | 4 | 2021 | 555 | 0.130 |
Why?
|
Hypertension | 1 | 2015 | 8431 | 0.130 |
Why?
|
Hyperinsulinism | 7 | 2008 | 415 | 0.130 |
Why?
|
Interleukin-1beta | 1 | 2020 | 970 | 0.130 |
Why?
|
Stress, Physiological | 1 | 2022 | 1405 | 0.130 |
Why?
|
Steroidogenic Factor 1 | 1 | 2014 | 46 | 0.120 |
Why?
|
Thiazoles | 1 | 2002 | 1488 | 0.120 |
Why?
|
Middle Aged | 31 | 2021 | 212863 | 0.120 |
Why?
|
Angiotensin II | 2 | 2015 | 880 | 0.120 |
Why?
|
Weight-Bearing | 1 | 2017 | 515 | 0.120 |
Why?
|
Oxidoreductases Acting on CH-NH Group Donors | 1 | 2014 | 62 | 0.120 |
Why?
|
Spermine | 1 | 2014 | 70 | 0.120 |
Why?
|
Ornithine Decarboxylase | 1 | 2014 | 63 | 0.120 |
Why?
|
rab GTP-Binding Proteins | 1 | 2016 | 247 | 0.120 |
Why?
|
Myocardial Contraction | 1 | 1999 | 1585 | 0.120 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 781 | 0.120 |
Why?
|
HEK293 Cells | 3 | 2018 | 4174 | 0.120 |
Why?
|
Adult | 34 | 2021 | 213394 | 0.120 |
Why?
|
Thyrotropin | 2 | 1988 | 849 | 0.120 |
Why?
|
Peptide Hormones | 1 | 2014 | 134 | 0.120 |
Why?
|
Mannose-Binding Lectins | 1 | 2014 | 100 | 0.120 |
Why?
|
COS Cells | 4 | 2002 | 1159 | 0.120 |
Why?
|
Immune System | 1 | 2019 | 801 | 0.120 |
Why?
|
Base Sequence | 9 | 2008 | 12804 | 0.120 |
Why?
|
Glycogen Synthase Kinase 3 | 3 | 2005 | 432 | 0.110 |
Why?
|
Atherosclerosis | 1 | 2009 | 3401 | 0.110 |
Why?
|
Gene Deletion | 4 | 2010 | 2757 | 0.110 |
Why?
|
Liver Glycogen | 3 | 2005 | 34 | 0.110 |
Why?
|
Immunoblotting | 8 | 2017 | 1683 | 0.110 |
Why?
|
Gastric Bypass | 1 | 2021 | 809 | 0.110 |
Why?
|
Acetyltransferases | 1 | 2014 | 236 | 0.110 |
Why?
|
Reference Values | 8 | 2008 | 4983 | 0.110 |
Why?
|
Naphthalimides | 1 | 2012 | 21 | 0.110 |
Why?
|
S-Adenosylmethionine | 1 | 2014 | 212 | 0.110 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2014 | 331 | 0.110 |
Why?
|
3-O-Methylglucose | 5 | 1998 | 37 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3863 | 0.110 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2015 | 691 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 2948 | 0.100 |
Why?
|
Cell Size | 5 | 2017 | 641 | 0.100 |
Why?
|
Niacinamide | 1 | 2014 | 415 | 0.100 |
Why?
|
Agouti-Related Protein | 1 | 2012 | 98 | 0.100 |
Why?
|
Antimetabolites | 1 | 2012 | 125 | 0.100 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 2 | 2005 | 38 | 0.100 |
Why?
|
Obesity, Morbid | 2 | 2020 | 1191 | 0.100 |
Why?
|
Proteome | 1 | 2021 | 1772 | 0.100 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2016 | 570 | 0.100 |
Why?
|
Myocardium | 4 | 2017 | 4788 | 0.100 |
Why?
|
Hexokinase | 2 | 2005 | 126 | 0.100 |
Why?
|
Rats, Zucker | 3 | 2000 | 128 | 0.100 |
Why?
|
Cell Line | 10 | 2016 | 15987 | 0.100 |
Why?
|
Blood Proteins | 1 | 1996 | 1122 | 0.100 |
Why?
|
Prostatic Neoplasms | 2 | 2014 | 10999 | 0.100 |
Why?
|
Time Factors | 14 | 2021 | 40050 | 0.100 |
Why?
|
Cell Proliferation | 3 | 2017 | 10455 | 0.100 |
Why?
|
Adrenergic Antagonists | 1 | 2011 | 24 | 0.100 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2010 | 234 | 0.100 |
Why?
|
Crosses, Genetic | 4 | 2013 | 799 | 0.100 |
Why?
|
Blotting, Northern | 5 | 2000 | 1583 | 0.100 |
Why?
|
Vasodilation | 1 | 2015 | 947 | 0.100 |
Why?
|
Taxoids | 1 | 2014 | 661 | 0.100 |
Why?
|
Protein Kinase C-epsilon | 2 | 2003 | 43 | 0.090 |
Why?
|
Glucose-6-Phosphate | 2 | 2005 | 30 | 0.090 |
Why?
|
Lectins, C-Type | 1 | 2014 | 586 | 0.090 |
Why?
|
Exercise | 4 | 2006 | 5591 | 0.090 |
Why?
|
Cell Differentiation | 6 | 2016 | 11460 | 0.090 |
Why?
|
Hepatocytes | 4 | 2021 | 1202 | 0.090 |
Why?
|
NAD | 1 | 2014 | 591 | 0.090 |
Why?
|
Receptors, Cell Surface | 2 | 2014 | 2864 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 1997 | 1674 | 0.090 |
Why?
|
Prosthesis-Related Infections | 1 | 2016 | 538 | 0.090 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2010 | 80 | 0.090 |
Why?
|
Adiponectin | 3 | 2013 | 1096 | 0.090 |
Why?
|
Drug Administration Schedule | 2 | 2009 | 4935 | 0.090 |
Why?
|
DNA-Binding Proteins | 6 | 2008 | 9622 | 0.090 |
Why?
|
Microsomes | 4 | 1997 | 257 | 0.090 |
Why?
|
Spleen | 1 | 2016 | 2359 | 0.090 |
Why?
|
Phosphatidylcholines | 1 | 1991 | 412 | 0.090 |
Why?
|
Food | 3 | 1990 | 760 | 0.090 |
Why?
|
Sympathetic Nervous System | 2 | 2003 | 514 | 0.090 |
Why?
|
Podocytes | 1 | 2013 | 392 | 0.090 |
Why?
|
Calorimetry, Indirect | 1 | 2009 | 182 | 0.090 |
Why?
|
Patch-Clamp Techniques | 1 | 2012 | 958 | 0.090 |
Why?
|
Streptozocin | 3 | 1997 | 191 | 0.090 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1654 | 0.090 |
Why?
|
Heterozygote | 1 | 2016 | 2798 | 0.090 |
Why?
|
Genetic Vectors | 3 | 2001 | 3419 | 0.090 |
Why?
|
Mice, Mutant Strains | 4 | 2012 | 1883 | 0.080 |
Why?
|
Cromolyn Sodium | 1 | 2009 | 87 | 0.080 |
Why?
|
Amino Acid Sequence | 9 | 2016 | 13816 | 0.080 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2011 | 515 | 0.080 |
Why?
|
Macrophage Activation | 1 | 2012 | 558 | 0.080 |
Why?
|
Protein Subunits | 1 | 2012 | 964 | 0.080 |
Why?
|
Symporters | 2 | 2003 | 364 | 0.080 |
Why?
|
Dietary Supplements | 1 | 2021 | 3279 | 0.080 |
Why?
|
Enzyme Inhibitors | 6 | 2011 | 3802 | 0.080 |
Why?
|
Phosphorus Radioisotopes | 1 | 1987 | 104 | 0.080 |
Why?
|
Recombination, Genetic | 1 | 2013 | 1591 | 0.080 |
Why?
|
Dietary Carbohydrates | 1 | 1993 | 904 | 0.080 |
Why?
|
Neuronal Plasticity | 1 | 2016 | 1416 | 0.080 |
Why?
|
Methylglycosides | 1 | 1987 | 10 | 0.080 |
Why?
|
Brain Chemistry | 2 | 2006 | 985 | 0.080 |
Why?
|
Receptors, Leptin | 2 | 2011 | 356 | 0.080 |
Why?
|
Resistin | 2 | 2005 | 170 | 0.080 |
Why?
|
Alkyl and Aryl Transferases | 2 | 1999 | 90 | 0.070 |
Why?
|
Subcellular Fractions | 2 | 2004 | 547 | 0.070 |
Why?
|
Hemangioma, Cavernous | 1 | 2008 | 110 | 0.070 |
Why?
|
Estrogens | 1 | 2014 | 1561 | 0.070 |
Why?
|
Aorta | 1 | 2015 | 2048 | 0.070 |
Why?
|
Ketosis | 1 | 2007 | 49 | 0.070 |
Why?
|
Ketone Bodies | 1 | 2007 | 82 | 0.070 |
Why?
|
Proto-Oncogenes | 1 | 2008 | 321 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 6 | 2013 | 3770 | 0.070 |
Why?
|
DNA | 5 | 1997 | 7275 | 0.070 |
Why?
|
Benzimidazoles | 1 | 2012 | 849 | 0.070 |
Why?
|
Genotype | 3 | 2017 | 12951 | 0.070 |
Why?
|
Ribonucleotides | 1 | 2006 | 116 | 0.070 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2006 | 88 | 0.070 |
Why?
|
Cathepsins | 1 | 2007 | 237 | 0.070 |
Why?
|
Glycogen Phosphorylase | 1 | 2005 | 16 | 0.070 |
Why?
|
Transfection | 7 | 2007 | 5884 | 0.070 |
Why?
|
Cytokines | 6 | 2012 | 7298 | 0.070 |
Why?
|
Intestine, Small | 1 | 1992 | 1242 | 0.070 |
Why?
|
Acute-Phase Proteins | 1 | 2007 | 261 | 0.070 |
Why?
|
Gluconeogenesis | 1 | 2007 | 183 | 0.070 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2006 | 2102 | 0.070 |
Why?
|
Hypertrophy | 2 | 2018 | 565 | 0.070 |
Why?
|
Phosphotyrosine | 2 | 2004 | 457 | 0.070 |
Why?
|
Injections, Intraperitoneal | 1 | 2006 | 423 | 0.070 |
Why?
|
Glycogen Synthase Kinases | 2 | 2002 | 40 | 0.070 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1987 | 349 | 0.070 |
Why?
|
Drug Resistance | 1 | 2012 | 1610 | 0.070 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2002 | 1800 | 0.070 |
Why?
|
Apyrase | 1 | 2008 | 364 | 0.070 |
Why?
|
Glycerol | 2 | 2007 | 277 | 0.070 |
Why?
|
Injections, Intravenous | 1 | 2008 | 1421 | 0.070 |
Why?
|
DNA Primers | 5 | 2004 | 2893 | 0.070 |
Why?
|
Neurosecretory Systems | 1 | 2006 | 230 | 0.070 |
Why?
|
Transcription, Genetic | 4 | 2008 | 7709 | 0.070 |
Why?
|
Viral Proteins | 1 | 2013 | 1900 | 0.070 |
Why?
|
Hypertriglyceridemia | 1 | 2008 | 294 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2009 | 774 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2002 | 1675 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 2 | 2012 | 1991 | 0.060 |
Why?
|
Gene Targeting | 2 | 2001 | 886 | 0.060 |
Why?
|
Cysteine Endopeptidases | 1 | 2007 | 561 | 0.060 |
Why?
|
Phosphotransferases | 2 | 2004 | 309 | 0.060 |
Why?
|
Receptors, Melanocortin | 1 | 2004 | 24 | 0.060 |
Why?
|
Cystinyl Aminopeptidase | 1 | 2004 | 2 | 0.060 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 3848 | 0.060 |
Why?
|
Waist Circumference | 1 | 2008 | 912 | 0.060 |
Why?
|
Fishes | 1 | 1987 | 563 | 0.060 |
Why?
|
Fructose | 2 | 2017 | 287 | 0.060 |
Why?
|
Mitochondria | 3 | 2018 | 3522 | 0.060 |
Why?
|
R-SNARE Proteins | 1 | 2004 | 75 | 0.060 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2007 | 256 | 0.060 |
Why?
|
Cell Compartmentation | 2 | 1997 | 400 | 0.060 |
Why?
|
Lipoproteins, VLDL | 1 | 2004 | 201 | 0.060 |
Why?
|
Phosphatidylinositol Phosphates | 1 | 2004 | 209 | 0.060 |
Why?
|
Cell Fractionation | 2 | 1996 | 253 | 0.060 |
Why?
|
STAT1 Transcription Factor | 2 | 2004 | 319 | 0.060 |
Why?
|
Nurses | 1 | 2013 | 2455 | 0.060 |
Why?
|
Protein Kinase C-alpha | 1 | 2003 | 112 | 0.060 |
Why?
|
Precipitin Tests | 1 | 2004 | 829 | 0.060 |
Why?
|
Cytosol | 2 | 1997 | 902 | 0.060 |
Why?
|
Disease Models, Animal | 5 | 2013 | 18003 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2001 | 489 | 0.060 |
Why?
|
Mammary Glands, Animal | 1 | 2004 | 276 | 0.060 |
Why?
|
Oncogene Proteins | 1 | 2007 | 750 | 0.060 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2005 | 430 | 0.060 |
Why?
|
Lactic Acid | 3 | 2007 | 1132 | 0.060 |
Why?
|
Hypothyroidism | 1 | 1988 | 659 | 0.050 |
Why?
|
Trans-Activators | 2 | 2004 | 2922 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2008 | 1141 | 0.050 |
Why?
|
Actins | 5 | 1998 | 2112 | 0.050 |
Why?
|
Cell Division | 4 | 2001 | 4575 | 0.050 |
Why?
|
Carbon | 1 | 2006 | 684 | 0.050 |
Why?
|
Feedback | 1 | 2006 | 788 | 0.050 |
Why?
|
Phentolamine | 1 | 2002 | 105 | 0.050 |
Why?
|
Lactates | 2 | 2001 | 434 | 0.050 |
Why?
|
Androstadienes | 2 | 2001 | 340 | 0.050 |
Why?
|
Dipeptidases | 1 | 2021 | 38 | 0.050 |
Why?
|
Radioimmunoassay | 2 | 1996 | 918 | 0.050 |
Why?
|
Hyperplasia | 2 | 2017 | 1181 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 3 | 2004 | 1285 | 0.050 |
Why?
|
Aged | 15 | 2019 | 162698 | 0.050 |
Why?
|
Arthroplasty, Replacement, Hip | 2 | 2005 | 1457 | 0.050 |
Why?
|
Mast Cells | 1 | 2009 | 1542 | 0.050 |
Why?
|
Aurothioglucose | 2 | 2002 | 11 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2012 | 19811 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2021 | 76 | 0.050 |
Why?
|
DNA Replication | 2 | 1999 | 1389 | 0.050 |
Why?
|
Cross-Sectional Studies | 6 | 2012 | 24714 | 0.050 |
Why?
|
Isoproterenol | 1 | 2002 | 399 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10142 | 0.050 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2002 | 174 | 0.050 |
Why?
|
Physical Education and Training | 1 | 2002 | 106 | 0.050 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2021 | 123 | 0.050 |
Why?
|
Atrial Natriuretic Factor | 2 | 1999 | 393 | 0.050 |
Why?
|
Protein Transport | 3 | 2016 | 1991 | 0.050 |
Why?
|
Hep G2 Cells | 2 | 2013 | 392 | 0.050 |
Why?
|
Genistein | 1 | 2001 | 84 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3506 | 0.050 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2004 | 365 | 0.050 |
Why?
|
Portal Vein | 1 | 2003 | 433 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 1988 | 9259 | 0.050 |
Why?
|
Ankle Joint | 1 | 2004 | 409 | 0.050 |
Why?
|
Adrenergic beta-Agonists | 1 | 2002 | 346 | 0.050 |
Why?
|
Injections, Intraventricular | 1 | 2000 | 232 | 0.050 |
Why?
|
Arthroplasty, Replacement | 1 | 2004 | 335 | 0.050 |
Why?
|
STAT3 Transcription Factor | 2 | 2004 | 875 | 0.050 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 489 | 0.050 |
Why?
|
Cricetinae | 4 | 2011 | 2468 | 0.050 |
Why?
|
Cohort Studies | 3 | 2013 | 40389 | 0.050 |
Why?
|
Physical Exertion | 2 | 1993 | 695 | 0.040 |
Why?
|
Transforming Growth Factor beta | 2 | 2018 | 1997 | 0.040 |
Why?
|
Health Status | 1 | 2013 | 4013 | 0.040 |
Why?
|
beta-Galactosidase | 2 | 2000 | 572 | 0.040 |
Why?
|
Vaginitis | 1 | 1999 | 46 | 0.040 |
Why?
|
Mice, Inbred Strains | 2 | 2007 | 1837 | 0.040 |
Why?
|
Genetic Variation | 3 | 2007 | 6539 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2005 | 3922 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2002 | 698 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2014 | 5148 | 0.040 |
Why?
|
Doxycycline | 1 | 2001 | 327 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2004 | 986 | 0.040 |
Why?
|
Neural Cell Adhesion Molecule L1 | 1 | 1999 | 40 | 0.040 |
Why?
|
Transcriptional Activation | 2 | 2018 | 1783 | 0.040 |
Why?
|
Xenopus laevis | 1 | 2003 | 953 | 0.040 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 1998 | 821 | 0.040 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 1999 | 126 | 0.040 |
Why?
|
Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 1998 | 14 | 0.040 |
Why?
|
Homozygote | 1 | 2003 | 1788 | 0.040 |
Why?
|
Thermosensing | 1 | 2018 | 57 | 0.040 |
Why?
|
Intracellular Membranes | 1 | 1999 | 389 | 0.040 |
Why?
|
Diabetes, Gestational | 1 | 2008 | 1174 | 0.040 |
Why?
|
Solid Phase Extraction | 1 | 2018 | 28 | 0.040 |
Why?
|
Heterosexuality | 1 | 2000 | 272 | 0.040 |
Why?
|
Coronary Disease | 1 | 2013 | 6068 | 0.040 |
Why?
|
Health Status Indicators | 1 | 2003 | 969 | 0.040 |
Why?
|
Hydrolysis | 1 | 2019 | 682 | 0.040 |
Why?
|
Neuropeptides | 1 | 2004 | 942 | 0.040 |
Why?
|
Genes, Reporter | 2 | 2004 | 1549 | 0.040 |
Why?
|
Alcohol Oxidoreductases | 1 | 1998 | 170 | 0.040 |
Why?
|
Glucose Transporter Type 5 | 1 | 2017 | 13 | 0.040 |
Why?
|
Receptor, IGF Type 1 | 3 | 2008 | 390 | 0.040 |
Why?
|
Adipocytes, Brown | 1 | 2018 | 139 | 0.040 |
Why?
|
Oxygen Consumption | 2 | 2018 | 1871 | 0.040 |
Why?
|
Antigens, CD | 1 | 2008 | 4024 | 0.040 |
Why?
|
Okadaic Acid | 1 | 1997 | 67 | 0.040 |
Why?
|
Survivors | 4 | 2003 | 2280 | 0.040 |
Why?
|
Quality of Life | 4 | 2003 | 12640 | 0.040 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 1997 | 102 | 0.040 |
Why?
|
Rats, Wistar | 2 | 2002 | 1894 | 0.040 |
Why?
|
Glucose Transporter Type 2 | 1 | 2017 | 62 | 0.040 |
Why?
|
Hip Dislocation | 1 | 2000 | 243 | 0.040 |
Why?
|
Glucose Transport Proteins, Facilitative | 1 | 2017 | 55 | 0.040 |
Why?
|
Muscle Contraction | 2 | 2000 | 1240 | 0.040 |
Why?
|
Indinavir | 1 | 2016 | 74 | 0.040 |
Why?
|
Life Style | 2 | 2007 | 3817 | 0.040 |
Why?
|
Aging | 5 | 2003 | 8613 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2016 | 1721 | 0.040 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2017 | 161 | 0.040 |
Why?
|
Gene Transfer Techniques | 2 | 2005 | 1227 | 0.040 |
Why?
|
Tritium | 1 | 2017 | 755 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2000 | 10945 | 0.040 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2003 | 2015 | 0.040 |
Why?
|
Hemostasis | 1 | 1999 | 459 | 0.040 |
Why?
|
Paraventricular Hypothalamic Nucleus | 1 | 2016 | 113 | 0.040 |
Why?
|
CHO Cells | 3 | 2011 | 1404 | 0.040 |
Why?
|
Methionine | 1 | 1999 | 591 | 0.040 |
Why?
|
Infusions, Intravenous | 2 | 2003 | 2270 | 0.040 |
Why?
|
Human Growth Hormone | 1 | 2021 | 683 | 0.040 |
Why?
|
Organ Size | 2 | 1999 | 2247 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2005 | 2910 | 0.030 |
Why?
|
Immunoprecipitation | 2 | 2012 | 903 | 0.030 |
Why?
|
Antibodies | 3 | 1995 | 2450 | 0.030 |
Why?
|
Regression Analysis | 2 | 2018 | 6452 | 0.030 |
Why?
|
Autocrine Communication | 1 | 2017 | 172 | 0.030 |
Why?
|
Guanosine Triphosphate | 1 | 1997 | 320 | 0.030 |
Why?
|
Protein Kinase C-delta | 1 | 1996 | 123 | 0.030 |
Why?
|
Weight Loss | 2 | 2007 | 2589 | 0.030 |
Why?
|
Antigens, Differentiation | 1 | 1999 | 925 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2001 | 1539 | 0.030 |
Why?
|
Substrate Specificity | 2 | 2016 | 1798 | 0.030 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 1995 | 57 | 0.030 |
Why?
|
Lipoprotein Lipase | 1 | 1996 | 126 | 0.030 |
Why?
|
Carbohydrates | 1 | 2018 | 387 | 0.030 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1998 | 495 | 0.030 |
Why?
|
Phenotype | 4 | 2011 | 16301 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2000 | 1793 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 1987 | 4522 | 0.030 |
Why?
|
Neuropeptide Y | 1 | 2016 | 200 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2010 | 625 | 0.030 |
Why?
|
Longevity | 1 | 2003 | 1066 | 0.030 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1995 | 246 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2002 | 1522 | 0.030 |
Why?
|
Lipase | 1 | 2017 | 315 | 0.030 |
Why?
|
Recurrence | 1 | 2006 | 8307 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 2018 | 2665 | 0.030 |
Why?
|
Metformin | 1 | 2002 | 827 | 0.030 |
Why?
|
Intraoperative Complications | 1 | 2002 | 1184 | 0.030 |
Why?
|
Epididymis | 2 | 1993 | 227 | 0.030 |
Why?
|
Dendritic Spines | 1 | 2016 | 233 | 0.030 |
Why?
|
Ribosomes | 1 | 1998 | 499 | 0.030 |
Why?
|
Integrins | 1 | 1999 | 845 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2005 | 2845 | 0.030 |
Why?
|
Carbohydrate Metabolism | 1 | 1995 | 265 | 0.030 |
Why?
|
Oligonucleotide Probes | 1 | 1995 | 425 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 5502 | 0.030 |
Why?
|
Mycobacterium | 1 | 2016 | 249 | 0.030 |
Why?
|
Food Deprivation | 1 | 1994 | 116 | 0.030 |
Why?
|
Epidemiologic Studies | 1 | 1998 | 677 | 0.030 |
Why?
|
Vagina | 1 | 1999 | 822 | 0.030 |
Why?
|
Receptors, Drug | 1 | 1994 | 161 | 0.030 |
Why?
|
Tumor Cells, Cultured | 4 | 1999 | 6310 | 0.030 |
Why?
|
Cloning, Molecular | 2 | 2016 | 4319 | 0.030 |
Why?
|
Muscular Diseases | 1 | 2018 | 555 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2016 | 576 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 1997 | 706 | 0.030 |
Why?
|
Pelvic Bones | 1 | 2016 | 264 | 0.030 |
Why?
|
Peptides | 4 | 1995 | 4395 | 0.030 |
Why?
|
Body Temperature Regulation | 1 | 2015 | 252 | 0.030 |
Why?
|
Fat Emulsions, Intravenous | 1 | 1996 | 321 | 0.030 |
Why?
|
Arthroplasty | 1 | 2016 | 304 | 0.030 |
Why?
|
Physical Examination | 1 | 1999 | 1231 | 0.030 |
Why?
|
Molecular Probes | 1 | 1995 | 318 | 0.030 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 1994 | 150 | 0.030 |
Why?
|
Prediabetic State | 2 | 2013 | 484 | 0.030 |
Why?
|
Epinephrine | 1 | 2016 | 795 | 0.030 |
Why?
|
Affinity Labels | 1 | 1992 | 109 | 0.030 |
Why?
|
Clathrin-Coated Vesicles | 1 | 2013 | 74 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1833 | 0.030 |
Why?
|
Genes | 3 | 1993 | 1898 | 0.030 |
Why?
|
Estrogen Replacement Therapy | 1 | 1999 | 1203 | 0.030 |
Why?
|
Receptors, Immunologic | 1 | 1999 | 1424 | 0.030 |
Why?
|
Membranes | 1 | 1992 | 174 | 0.030 |
Why?
|
Breast Neoplasms | 4 | 2003 | 20676 | 0.030 |
Why?
|
Creatine Kinase | 2 | 2007 | 694 | 0.030 |
Why?
|
Caloric Restriction | 2 | 2007 | 303 | 0.030 |
Why?
|
Consensus Development Conferences, NIH as Topic | 1 | 2012 | 28 | 0.030 |
Why?
|
Knee Prosthesis | 1 | 2016 | 425 | 0.030 |
Why?
|
Menopause | 1 | 2000 | 1613 | 0.030 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1992 | 79 | 0.030 |
Why?
|
Infusions, Intraventricular | 1 | 2011 | 36 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2013 | 195 | 0.030 |
Why?
|
Housing, Animal | 1 | 2011 | 48 | 0.030 |
Why?
|
Gene Silencing | 1 | 2018 | 1537 | 0.030 |
Why?
|
Glucosephosphates | 1 | 1991 | 20 | 0.030 |
Why?
|
Macrophages, Peritoneal | 1 | 2013 | 251 | 0.030 |
Why?
|
Microtubules | 1 | 1998 | 1088 | 0.030 |
Why?
|
Haplorhini | 1 | 1992 | 558 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 1996 | 785 | 0.030 |
Why?
|
Chromatography, Affinity | 1 | 1992 | 550 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 1999 | 1557 | 0.020 |
Why?
|
Point Mutation | 1 | 1997 | 1626 | 0.020 |
Why?
|
Workflow | 1 | 2016 | 831 | 0.020 |
Why?
|
Rodentia | 1 | 1992 | 260 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 1998 | 1310 | 0.020 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 1994 | 640 | 0.020 |
Why?
|
Exercise Therapy | 1 | 1998 | 897 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 1994 | 562 | 0.020 |
Why?
|
Tissue Culture Techniques | 1 | 2011 | 291 | 0.020 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2002 | 1458 | 0.020 |
Why?
|
Deoxycytidine | 1 | 1994 | 825 | 0.020 |
Why?
|
Postmenopause | 1 | 1999 | 2456 | 0.020 |
Why?
|
Acromegaly | 1 | 1993 | 348 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 2 | 2001 | 122 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 2 | 1991 | 2503 | 0.020 |
Why?
|
Rabbits | 2 | 1995 | 4882 | 0.020 |
Why?
|
Pancreas | 2 | 2008 | 1678 | 0.020 |
Why?
|
Hip Prosthesis | 1 | 2016 | 918 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 2009 | 96 | 0.020 |
Why?
|
Erythroid Precursor Cells | 1 | 1990 | 217 | 0.020 |
Why?
|
Dexamethasone | 1 | 1997 | 1948 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2013 | 1203 | 0.020 |
Why?
|
Albuminuria | 1 | 2013 | 692 | 0.020 |
Why?
|
Duodenum | 1 | 1992 | 481 | 0.020 |
Why?
|
Cell Separation | 1 | 1995 | 1739 | 0.020 |
Why?
|
DNA Probes | 1 | 1990 | 561 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6942 | 0.020 |
Why?
|
Adolescent | 5 | 2009 | 85405 | 0.020 |
Why?
|
Immediate-Early Proteins | 1 | 1992 | 453 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2004 | 3689 | 0.020 |
Why?
|
Multigene Family | 1 | 1992 | 1107 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2018 | 1957 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 4743 | 0.020 |
Why?
|
Endocytosis | 1 | 2013 | 984 | 0.020 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1988 | 147 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2012 | 780 | 0.020 |
Why?
|
Tamoxifen | 1 | 2013 | 978 | 0.020 |
Why?
|
Ictaluridae | 1 | 1987 | 7 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 15500 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 1999 | 3768 | 0.020 |
Why?
|
Longitudinal Studies | 3 | 2008 | 13880 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1995 | 2131 | 0.020 |
Why?
|
Aspartic Acid | 2 | 2000 | 575 | 0.020 |
Why?
|
Farnesyltranstransferase | 2 | 1999 | 76 | 0.020 |
Why?
|
Radioligand Assay | 1 | 1988 | 379 | 0.020 |
Why?
|
Cathepsin L | 1 | 2007 | 75 | 0.020 |
Why?
|
Epithelium | 1 | 1992 | 1684 | 0.020 |
Why?
|
Islets of Langerhans Transplantation | 1 | 1993 | 742 | 0.020 |
Why?
|
Adaptation, Psychological | 2 | 1996 | 2564 | 0.020 |
Why?
|
Exons | 1 | 1993 | 2430 | 0.020 |
Why?
|
Nucleotidases | 1 | 1987 | 31 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2000 | 5076 | 0.020 |
Why?
|
Oocytes | 1 | 1992 | 1185 | 0.020 |
Why?
|
NADH Dehydrogenase | 1 | 1987 | 43 | 0.020 |
Why?
|
Goats | 1 | 1987 | 172 | 0.020 |
Why?
|
Sulfonamides | 1 | 1997 | 1934 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2010 | 888 | 0.020 |
Why?
|
Knee Joint | 1 | 2016 | 1676 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2007 | 129 | 0.020 |
Why?
|
Epoxy Compounds | 1 | 2007 | 135 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 1993 | 1330 | 0.020 |
Why?
|
Doxorubicin | 1 | 2013 | 2218 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1156 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2021 | 76631 | 0.020 |
Why?
|
Heart | 2 | 1998 | 4466 | 0.020 |
Why?
|
Follow-Up Studies | 5 | 2013 | 38942 | 0.020 |
Why?
|
Lipocalins | 1 | 2007 | 170 | 0.020 |
Why?
|
Horses | 1 | 1987 | 306 | 0.020 |
Why?
|
Phosphorus | 1 | 1987 | 338 | 0.020 |
Why?
|
Adenosine Triphosphate | 2 | 2008 | 2022 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1618 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 2013 | 981 | 0.020 |
Why?
|
Sjogren's Syndrome | 1 | 1988 | 229 | 0.020 |
Why?
|
Models, Animal | 2 | 2004 | 2164 | 0.020 |
Why?
|
5'-Nucleotidase | 1 | 1987 | 159 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 2208 | 0.020 |
Why?
|
Motor Activity | 2 | 2007 | 2719 | 0.020 |
Why?
|
RNA, Small Interfering | 2 | 2005 | 3498 | 0.020 |
Why?
|
Postoperative Complications | 3 | 2005 | 15194 | 0.020 |
Why?
|
Sex Characteristics | 1 | 1996 | 2583 | 0.020 |
Why?
|
Galactosyltransferases | 1 | 1987 | 261 | 0.020 |
Why?
|
Cystic Fibrosis | 1 | 1994 | 1177 | 0.020 |
Why?
|
Environment | 1 | 2011 | 1110 | 0.020 |
Why?
|
Antibodies, Phospho-Specific | 1 | 2005 | 12 | 0.020 |
Why?
|
Germany | 1 | 2007 | 853 | 0.020 |
Why?
|
Fibroblasts | 3 | 2005 | 4137 | 0.020 |
Why?
|
Lac Operon | 1 | 2005 | 238 | 0.020 |
Why?
|
Drug Discovery | 1 | 2013 | 1056 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2008 | 1801 | 0.020 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2005 | 86 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 1992 | 1409 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2007 | 591 | 0.020 |
Why?
|
Gene Amplification | 1 | 2008 | 1061 | 0.020 |
Why?
|
Protein Binding | 1 | 1996 | 9375 | 0.020 |
Why?
|
STAT5 Transcription Factor | 1 | 2004 | 262 | 0.020 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2007 | 502 | 0.010 |
Why?
|
Milk Proteins | 1 | 2004 | 168 | 0.010 |
Why?
|
Muscle Cells | 1 | 2005 | 196 | 0.010 |
Why?
|
rho-Associated Kinases | 1 | 2005 | 279 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2009 | 1374 | 0.010 |
Why?
|
Fibronectins | 1 | 2007 | 723 | 0.010 |
Why?
|
Mutation | 2 | 2005 | 29658 | 0.010 |
Why?
|
Placenta | 1 | 1992 | 1682 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2007 | 6174 | 0.010 |
Why?
|
Pregnancy | 3 | 2008 | 29002 | 0.010 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2004 | 718 | 0.010 |
Why?
|
Body Constitution | 1 | 2003 | 273 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2007 | 1992 | 0.010 |
Why?
|
Osteolysis | 1 | 2004 | 270 | 0.010 |
Why?
|
Lactation | 1 | 2004 | 410 | 0.010 |
Why?
|
Sirolimus | 2 | 2000 | 1559 | 0.010 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2002 | 137 | 0.010 |
Why?
|
Rats, Inbred BN | 1 | 2001 | 236 | 0.010 |
Why?
|
Creatine Kinase, MM Form | 1 | 2001 | 12 | 0.010 |
Why?
|
Depression, Chemical | 1 | 2001 | 191 | 0.010 |
Why?
|
Stromal Cells | 1 | 2007 | 1350 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2727 | 0.010 |
Why?
|
Diaphragm | 1 | 2003 | 347 | 0.010 |
Why?
|
NF-kappa B | 1 | 2010 | 2502 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2002 | 2455 | 0.010 |
Why?
|
Risk Factors | 3 | 2013 | 71974 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2002 | 284 | 0.010 |
Why?
|
Thymidine | 1 | 2001 | 317 | 0.010 |
Why?
|
Temperature | 1 | 1987 | 2202 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 2005 | 11347 | 0.010 |
Why?
|
Sex Counseling | 1 | 2000 | 17 | 0.010 |
Why?
|
Amino Acids | 1 | 2007 | 1727 | 0.010 |
Why?
|
Sodium-Phosphate Cotransporter Proteins | 1 | 2000 | 7 | 0.010 |
Why?
|
Blood Loss, Surgical | 1 | 2005 | 658 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 1988 | 1253 | 0.010 |
Why?
|
Erythrocytes | 1 | 1990 | 2453 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 2001 | 860 | 0.010 |
Why?
|
Thyroid Hormones | 1 | 2003 | 387 | 0.010 |
Why?
|
Sexual Behavior | 2 | 2003 | 2040 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 2005 | 1092 | 0.010 |
Why?
|
Length of Stay | 2 | 2005 | 6295 | 0.010 |
Why?
|
Nutritional Status | 1 | 1988 | 1587 | 0.010 |
Why?
|
Amenorrhea | 1 | 2003 | 485 | 0.010 |
Why?
|
Insulin Infusion Systems | 1 | 2001 | 212 | 0.010 |
Why?
|
Sex Factors | 1 | 1993 | 10398 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2001 | 480 | 0.010 |
Why?
|
Demography | 2 | 1996 | 1650 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12237 | 0.010 |
Why?
|
Kidney Tubules | 1 | 2001 | 487 | 0.010 |
Why?
|
Pyruvic Acid | 1 | 2000 | 197 | 0.010 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2000 | 191 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2005 | 1142 | 0.010 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 1999 | 120 | 0.010 |
Why?
|
Eukaryotic Initiation Factors | 1 | 1999 | 92 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2008 | 1890 | 0.010 |
Why?
|
Janus Kinase 2 | 1 | 2002 | 527 | 0.010 |
Why?
|
Reproduction | 1 | 2003 | 666 | 0.010 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 1999 | 183 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10362 | 0.010 |
Why?
|
Sickness Impact Profile | 1 | 1999 | 305 | 0.010 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1998 | 222 | 0.010 |
Why?
|
Ouabain | 1 | 1998 | 264 | 0.010 |
Why?
|
Inflammatory Bowel Diseases | 1 | 1992 | 2397 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1431 | 0.010 |
Why?
|
Calmodulin | 1 | 1998 | 209 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7136 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2004 | 2110 | 0.010 |
Why?
|
Mammals | 1 | 2003 | 1112 | 0.010 |
Why?
|
Anesthesia, Conduction | 1 | 2000 | 240 | 0.010 |
Why?
|
Alcoholism | 1 | 1988 | 1892 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2000 | 853 | 0.010 |
Why?
|
Research Design | 1 | 2013 | 5959 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2007 | 3194 | 0.010 |
Why?
|
Catalysis | 1 | 1998 | 759 | 0.010 |
Why?
|
Arginine | 1 | 2000 | 945 | 0.010 |
Why?
|
Vaginal Smears | 1 | 1999 | 512 | 0.010 |
Why?
|
Polymorphism, Genetic | 2 | 2000 | 4332 | 0.010 |
Why?
|
src-Family Kinases | 1 | 1999 | 549 | 0.010 |
Why?
|
Transferases | 1 | 1996 | 76 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15153 | 0.010 |
Why?
|
Hexoses | 1 | 1995 | 30 | 0.010 |
Why?
|
Receptors, Adrenergic, beta-1 | 1 | 1995 | 51 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2000 | 689 | 0.010 |
Why?
|
Receptors, Adrenergic, beta-3 | 1 | 1995 | 63 | 0.010 |
Why?
|
Chromones | 1 | 1996 | 155 | 0.010 |
Why?
|
Binding Sites | 1 | 2005 | 6113 | 0.010 |
Why?
|
RNA Interference | 1 | 2005 | 2899 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6361 | 0.010 |
Why?
|
Pyridines | 1 | 2007 | 2810 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2002 | 3510 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 21694 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2007 | 3752 | 0.010 |
Why?
|
Flavonoids | 1 | 1998 | 443 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2003 | 3453 | 0.010 |
Why?
|
Prospective Studies | 2 | 2013 | 53037 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16646 | 0.010 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 1995 | 201 | 0.010 |
Why?
|
Atrophy | 1 | 1999 | 1571 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1998 | 2049 | 0.010 |
Why?
|
Keratinocytes | 1 | 1999 | 793 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1999 | 2558 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2000 | 2092 | 0.010 |
Why?
|
Behavior Therapy | 1 | 2000 | 865 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2005 | 57650 | 0.010 |
Why?
|
Age of Onset | 1 | 2001 | 3263 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2008 | 62693 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2833 | 0.010 |
Why?
|
Glyburide | 1 | 1994 | 112 | 0.010 |
Why?
|
Calcium | 2 | 1998 | 5742 | 0.010 |
Why?
|
Somatomedins | 1 | 1993 | 192 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 1999 | 1599 | 0.010 |
Why?
|
Morpholines | 1 | 1996 | 562 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2001 | 1357 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2004 | 3671 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 1993 | 683 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1992 | 441 | 0.010 |
Why?
|
Pancreas Transplantation | 1 | 1993 | 187 | 0.010 |
Why?
|
Early Growth Response Protein 1 | 1 | 1992 | 139 | 0.010 |
Why?
|
Molecular Conformation | 1 | 1993 | 565 | 0.010 |
Why?
|
Chronic Disease | 1 | 2007 | 9133 | 0.010 |
Why?
|
Weight Gain | 1 | 2002 | 2278 | 0.010 |
Why?
|
Immune Sera | 1 | 1992 | 639 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2002 | 2716 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2003 | 3615 | 0.010 |
Why?
|
Hepatic Veins | 1 | 1991 | 112 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 1994 | 1144 | 0.010 |
Why?
|
Biopsy | 2 | 1993 | 6722 | 0.010 |
Why?
|
Radioisotope Dilution Technique | 1 | 1990 | 70 | 0.010 |
Why?
|
Smoking | 1 | 1988 | 8960 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2000 | 2965 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2000 | 2552 | 0.010 |
Why?
|
Electron Transport Complex IV | 1 | 1990 | 189 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2000 | 2275 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 1999 | 6397 | 0.010 |
Why?
|
Molecular Weight | 1 | 1992 | 2257 | 0.010 |
Why?
|
Potassium | 1 | 1994 | 1337 | 0.010 |
Why?
|
Skin | 1 | 2003 | 4324 | 0.010 |
Why?
|
Hippocampus | 1 | 2002 | 3657 | 0.010 |
Why?
|
Carbon Radioisotopes | 1 | 1990 | 596 | 0.010 |
Why?
|
Radiography | 1 | 2000 | 6998 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 1999 | 1957 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 1992 | 864 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1992 | 782 | 0.000 |
Why?
|
Gene Expression Profiling | 1 | 2004 | 9387 | 0.000 |
Why?
|
Cell Cycle Proteins | 1 | 1999 | 3433 | 0.000 |
Why?
|
Renin-Angiotensin System | 1 | 1992 | 763 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15070 | 0.000 |
Why?
|
Risk | 1 | 1999 | 9684 | 0.000 |
Why?
|
Syndrome | 1 | 1993 | 3241 | 0.000 |
Why?
|
HIV Infections | 1 | 1992 | 16764 | 0.000 |
Why?
|
Social Support | 1 | 1996 | 2112 | 0.000 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 1994 | 2026 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2007 | 17384 | 0.000 |
Why?
|
Administration, Oral | 1 | 1993 | 3909 | 0.000 |
Why?
|
Affect | 1 | 1992 | 1475 | 0.000 |
Why?
|
Mass Screening | 1 | 2000 | 5265 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1999 | 14740 | 0.000 |
Why?
|
Neuroblastoma | 1 | 1992 | 1214 | 0.000 |
Why?
|
United States | 1 | 2012 | 69573 | 0.000 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1992 | 2241 | 0.000 |
Why?
|
RNA | 1 | 1993 | 2723 | 0.000 |
Why?
|
Psychometrics | 1 | 1992 | 2995 | 0.000 |
Why?
|
Activities of Daily Living | 1 | 1992 | 2410 | 0.000 |
Why?
|
Patient Satisfaction | 1 | 1996 | 3382 | 0.000 |
Why?
|
Young Adult | 1 | 2009 | 56255 | 0.000 |
Why?
|
Child | 1 | 2009 | 77033 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 35326 | 0.000 |
Why?
|
Kidney Transplantation | 1 | 1993 | 4220 | 0.000 |
Why?
|
Glioma | 1 | 1992 | 3378 | 0.000 |
Why?
|
Adenocarcinoma | 1 | 1994 | 6318 | 0.000 |
Why?
|